Research Article

Matairesinol induced antiproliferative effects via mitochondrial dysfunction in HepG2 cells

Volume: 28 Number: 6 June 28, 2025

Matairesinol induced antiproliferative effects via mitochondrial dysfunction in HepG2 cells

Abstract

Hepatocellular carcinoma is one of the most severe and life-threatening types of cancer. The conventional treatment of hepatoma has significant challenges due to the adverse effects of chemotherapy, leading to treatment failure and decreased survival. Therefore, developing and investigating novel and safer anticancer drugs and establishing more effective therapeutic regimens is a crucial field of research. The Haplophyllum megalanthum-derived compound matairesinol has demonstrated antiproliferative and antitumor activity against various types of cancer, including pancreatic, breast, and prostate cancer. However, the potential effects of matairesinol on liver cancer, as well as the underlying molecular mechanisms associated with its anticancer activity, have yet to be thoroughly elucidated. In the current study, we demonstrated that matairesinol inhibited the viability of human hepatoma cells in a dose-dependent manner. Besides, at IC50 and higher doses, matairesinol induced oxidative stress and impaired mitochondrial membrane potential and ATP levels, two evidence of mitochondrial damage. Moreover, matairesinol exposure led to significant caspase-3 activation, a hallmark of apoptosis. These results indicate that mitochondrial damage and caspase-3 activation may contribute to the cytotoxic effect of matairesinol on liver cancer cells.

Keywords

References

  1. [1] Luo XY, Wu KM, He XX. Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets. J Exp Clin Cancer Res. 2021;40(1):172. https://doi.org/10.1186/s13046-021-01968-w
  2. [2] Wang J, Jiang YF. Natural compounds as anticancer agents: Experimental evidence. World J Exp Med. 2012;2(3):45 57. https://doi.org/10.5493/wjem.v2.i3.45
  3. [3] Lin SR, Chang CH, Hsu CF, Torvaldson E, Holmbom T, Eklund P, Unkila M, Sjöholm R, Eriksson JE. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br J Pharmacol. 2020;177(6):1409-1423. https://doi.org/10.1111/bph.14816
  4. [4] Sung YY, Lee AY, Kim HK. Forsythia suspensa fruit extracts and the constituent matairesinol confer anti-allergic effects in an allergic dermatitis mouse model. J Ethnopharmacol. 2016;187:49-56. https://doi.org/10.1016/j.jep.2016.04.015
  5. [5] Chang H, Wang Y, Gao X, Song Z, Awale S, Han N, Liu Z, Yin J. Lignans from the root of Wikstroemia indica and their cytotoxic activity against PANC-1 human pancreatic cancer cells. Fitoterapia. 2017;121: 31–37. https://doi.org/10.1016/j.fitote.2017.06.012
  6. [6] Mahajan M, Suryavanshi S, Bhowmick S, Alasmary FA, Almutairi TM, Islam MA, Kaul-Ghanekar R. Matairesinol, an active constituent of HC9 polyherbal formulation, exhibits HDAC8 inhibitory and anticancer activity. Biophys Chem. 2021;273:106588. https://doi.org/10.1016/j.bpc.2021.106588
  7. [7] Peuhu E, Rivero-Müller A, Stykki H, Torvaldson E, Holmbom T, Eklund P, Unkila M, Sjöholm R, Eriksson JE. Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis. Oncogene. 2010;29(6):898-908. https://doi.org/10.1038/onc.2009.386
  8. [8] Wang C, Youle RJ. The role of mitochondria in apoptosis. Annu Rev Genet. 2009;43:95-118. https://doi.org/10.1146/annurev-genet-102108-134850

Details

Primary Language

English

Subjects

Pharmaceutical Toxicology

Journal Section

Research Article

Publication Date

June 28, 2025

Submission Date

December 10, 2023

Acceptance Date

February 29, 2024

Published in Issue

Year 2024 Volume: 28 Number: 6

APA
Arzuk, E., Ergüç, A., Demir, S., Ünver Somer, N., Tan, İ., & Atış, E. (2025). Matairesinol induced antiproliferative effects via mitochondrial dysfunction in HepG2 cells. Journal of Research in Pharmacy, 28(6), 2001-2007. https://izlik.org/JA75PW54EM
AMA
1.Arzuk E, Ergüç A, Demir S, Ünver Somer N, Tan İ, Atış E. Matairesinol induced antiproliferative effects via mitochondrial dysfunction in HepG2 cells. J. Res. Pharm. 2025;28(6):2001-2007. https://izlik.org/JA75PW54EM
Chicago
Arzuk, Ege, Ali Ergüç, Serhat Demir, Nehir Ünver Somer, İclal Tan, and Ecrin Atış. 2025. “Matairesinol Induced Antiproliferative Effects via Mitochondrial Dysfunction in HepG2 Cells”. Journal of Research in Pharmacy 28 (6): 2001-7. https://izlik.org/JA75PW54EM.
EndNote
Arzuk E, Ergüç A, Demir S, Ünver Somer N, Tan İ, Atış E (July 1, 2025) Matairesinol induced antiproliferative effects via mitochondrial dysfunction in HepG2 cells. Journal of Research in Pharmacy 28 6 2001–2007.
IEEE
[1]E. Arzuk, A. Ergüç, S. Demir, N. Ünver Somer, İ. Tan, and E. Atış, “Matairesinol induced antiproliferative effects via mitochondrial dysfunction in HepG2 cells”, J. Res. Pharm., vol. 28, no. 6, pp. 2001–2007, July 2025, [Online]. Available: https://izlik.org/JA75PW54EM
ISNAD
Arzuk, Ege - Ergüç, Ali - Demir, Serhat - Ünver Somer, Nehir - Tan, İclal - Atış, Ecrin. “Matairesinol Induced Antiproliferative Effects via Mitochondrial Dysfunction in HepG2 Cells”. Journal of Research in Pharmacy 28/6 (July 1, 2025): 2001-2007. https://izlik.org/JA75PW54EM.
JAMA
1.Arzuk E, Ergüç A, Demir S, Ünver Somer N, Tan İ, Atış E. Matairesinol induced antiproliferative effects via mitochondrial dysfunction in HepG2 cells. J. Res. Pharm. 2025;28:2001–2007.
MLA
Arzuk, Ege, et al. “Matairesinol Induced Antiproliferative Effects via Mitochondrial Dysfunction in HepG2 Cells”. Journal of Research in Pharmacy, vol. 28, no. 6, July 2025, pp. 2001-7, https://izlik.org/JA75PW54EM.
Vancouver
1.Ege Arzuk, Ali Ergüç, Serhat Demir, Nehir Ünver Somer, İclal Tan, Ecrin Atış. Matairesinol induced antiproliferative effects via mitochondrial dysfunction in HepG2 cells. J. Res. Pharm. [Internet]. 2025 Jul. 1;28(6):2001-7. Available from: https://izlik.org/JA75PW54EM